These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35693143)

  • 1. Clinical Significance of Diffusion-weighted Magnetic Resonance Imaging on Treatment Efficacy in MS Patients With Acute Attacks.
    Asaadi F; Faeghi F; Ashrafi F; Sanei Taheri M
    Basic Clin Neurosci; 2021; 12(6):729-736. PubMed ID: 35693143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack.
    Yurtsever I; Hakyemez B; Taskapilioglu O; Erdogan C; Turan OF; Parlak M
    Eur J Radiol; 2008 Mar; 65(3):421-6. PubMed ID: 17587524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent diffusion coefficient measurements in normal appearing white matter may support the differential diagnosis between multiple sclerosis lesions and other white matter hyperintensities.
    Zacharzewska-Gondek A; Pokryszko-Dragan A; Gondek TM; Kołtowska A; Gruszka E; Budrewicz S; Sąsiadek M; Bladowska J
    J Neurol Sci; 2019 Feb; 397():24-30. PubMed ID: 30580051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion magnetic resonance imaging of normal-appearing white matter in multiple sclerosis: correlation with brain volume and clinical disability.
    Larassati H; Pandelaki J; Estiasari R; Prihartono J; Firdausia S; Yunus RE; Mulyadi R
    J Cent Nerv Syst Dis; 2022; 14():11795735221098147. PubMed ID: 35572123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.
    Anik Y; Demirci A; Efendi H; Bulut SS; Celebi I; Komsuoglu S
    Clin Neuroradiol; 2011 Nov; 21(4):207-15. PubMed ID: 21847666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.
    Temel S; Keklikoğlu HD; Vural G; Deniz O; Ercan K
    Neuroradiol J; 2013 Feb; 26(1):3-17. PubMed ID: 23859160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
    Gratsias G; Kapsalaki E; Kogia S; Dardiotis E; Tsimourtou V; Lavdas E; Kousi E; Pelekanou A; Hadjigeorgiou GM; Fezoulidis I
    Acta Neurol Belg; 2015 Jun; 115(2):111-6. PubMed ID: 25073775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
    Hori M; Yoshida M; Yokoyama K; Kamagata K; Kumagai F; Fukunaga I; Kamiya K; Suzuki M; Masutani Y; Hamasaki N; Suzuki Y; Kyogoku S; Hattori N; Aoki S
    Magn Reson Imaging; 2014 Jul; 32(6):625-9. PubMed ID: 24726649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
    Sahin T; Bozgeyik Z; Menzilcioglu MS; Citil S; Erbay MF
    Pol J Radiol; 2015; 80():544-8. PubMed ID: 26740826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter.
    Guo AC; MacFall JR; Provenzale JM
    Radiology; 2002 Mar; 222(3):729-36. PubMed ID: 11867792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.
    Heckova E; Dal-Bianco A; Strasser B; Hangel GJ; Lipka A; Motyka S; Hingerl L; Rommer PS; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
    Radiology; 2022 Apr; 303(1):141-150. PubMed ID: 34981978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Degradation of the Selected Projectile, Commissural and Association White Matter Tracts Within Normal Appearing White Matter in Patients with Multiple Sclerosis Using Diffusion Tensor MR Imaging - a Preliminary Study.
    Banaszek A; Bladowska J; Pokryszko-Dragan A; Podemski R; Sąsiadek MJ
    Pol J Radiol; 2015; 80():457-63. PubMed ID: 26516389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.
    Zivadinov R; Bergsland N; Stosic M; Sharma J; Nussenbaum F; Durfee J; Hani N; Abdelrahman N; Jaisani Z; Minagar A; Hoque R; Munschauer FE; Dwyer MG
    Neurol Res; 2008 Oct; 30(8):816-26. PubMed ID: 18826808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques.
    Arashloo FT; Hanzaei FF; Sedighi B; Amjad G; Younesi L
    J Family Med Prim Care; 2019 Jul; 8(7):2409-2413. PubMed ID: 31463267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions.
    Tievsky AL; Ptak T; Farkas J
    AJNR Am J Neuroradiol; 1999 Sep; 20(8):1491-9. PubMed ID: 10512236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between contrast enhanced plaques and plaque diffusion restriction and their signal intensities in FLAIR images in patients who admitted with acute symptoms of multiple sclerosis.
    Foroughi AA; Zare N; Saeedi-Moghadam M; Zeinali-Rafsanjani B; Nazeri M
    J Med Imaging Radiat Sci; 2021 Mar; 52(1):121-126. PubMed ID: 33446443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is It Possible to Discriminate Active MS Lesions with Diffusion Weighted Imaging?
    Unal S; Peker E; Erdogan S; Erden MI
    Eurasian J Med; 2019 Oct; 51(3):219-223. PubMed ID: 31692763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.